Alembic Pharmaceuticals Ltd
Alembic Pharma | 533573
APLLTD - Share Price Chart
Stock Performance
Ratios
About Company
- Alembic Pharmaceuticals Limited is a leading research-driven, integrated pharmaceutical enterprise specialising in the development and manufacturing of generic formulations across diverse therapeutic areas, including cardiology, anti-infective, gynaecology, ophthalmology, oncology and chronic therapies
- Alembic Pharmaceuticals Limited was incorporated on June 16, 2010 as a wholly owned subsidiary of Alembic Limited
- The company is engaged in pharmaceuticals business
- As per the Scheme of Arrangement, the 'Pharmaceutical Undertaking' of Alembic Limited got demerged and transferred to the Company with effect from April 1, 2010
- In April 2011, the company ceased to be a subsidiary of Alembic Ltd consequent to the allotment of 13,35,15,914 equity shares of Rs 2 each to the shareholders of Alembic Ltd as per the scheme of arrangement
- The shareholding of Alembic Ltd in the company reduced from 100% to 29
- Thus, the company became an associate of Alembic Ltd
- In September 2011, the equity shares of the company were listed on the Bombay Stock Exchange and National Stock Exchange
- During 2012, Alembic and Breckenridge Announced Paragraph IV ANDA Litigation with Pfizer on Desvenlafaxine (Pristiq)
- The company enters into a product development and license agreement with Accu-Break Pharmaceuticals, Inc, USA
Ethics: Alembic Pharmaceuticals Ltd is flagged for
Animal Cruelty
The company engages directly in some form of animal cruelty through its business.
Adequate
The company demonstrates adequate ESG practices with room for improvement.
Research Calls
Technical Indicators
Pivot Points
Volume Analysis
Growth Rate
All figures in ₹ Crores
No Information Available
No shareholding data available at this time.
News
No Information Available
Peers
#IndiaInvests
Trusted by 2.5 lac + Indians for their wealth-building needs
Top Losers
Group Stocks
Frequently Asked Questions
What is Share Price of Alembic Pharmaceuticals Ltd?
The current share price of Alembic Pharmaceuticals Ltd (Alembic Pharma) is ₹800.50. This price reflects the latest market valuation and is updated in real-time during trading hours.
What is the P/E Ratio of Alembic Pharmaceuticals Ltd?
The Price-to-Earnings (P/E) ratio of Alembic Pharmaceuticals Ltd is 21.96. This indicates how much investors are willing to pay per rupee of earnings, helping assess if the stock is overvalued or undervalued.
What is the 52-week high and low of Alembic Pharmaceuticals Ltd?
Alembic Pharmaceuticals Ltd has a 52-week high of ₹998.00 and a 52-week low of ₹635.80. This range shows the stock's price volatility over the past year.
What is the Dividend Yield of Alembic Pharmaceuticals Ltd?
Alembic Pharmaceuticals Ltd offers a dividend yield of 1.44%. This represents the annual dividend payment as a percentage of the current stock price, indicating the income return for investors.
What is the EPS of Alembic Pharmaceuticals Ltd?
The Earnings Per Share (EPS) of Alembic Pharmaceuticals Ltd is ₹37.96. EPS indicates the company's profitability on a per-share basis and is a key metric for evaluating financial performance.
What is the ROE of Alembic Pharmaceuticals Ltd?
Alembic Pharmaceuticals Ltd has a Return on Equity (ROE) of 12.90%. ROE measures how effectively the company uses shareholders' equity to generate profits, with higher values generally indicating better performance.
Disclaimer:
Please note that the above list and information is for research purposes only and are not recommendations. Do your own due diligence or consult an investment advisor before investing. The above data is dynamic in nature and subject to real-time changes and is derived from CMOTS.
